Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 2019.
Article Versions
- You are currently viewing a Latest version of this article (March 1, 2019 - 04:00).
- latest version (May 1, 2019 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2019 The Journal of Rheumatology
Author Information
- Désirée van der Heijde,
- Dafna D. Gladman,
- Oliver FitzGerald,
- Arthur Kavanaugh,
- Daniela Graham,
- Cunshan Wang and
- Lara Fallon
- From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St Vincent’s University Hospital, Dublin, Ireland; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego School of Medicine, La Jolla, San Diego, California, USA; Pfizer Inc, Groton, Connecticut, USA; Pfizer Inc, Montreal, QC, Canada.
This study was funded by Pfizer Inc.
DvdH has received consultancy fees from AbbVie, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Daiichi, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Janssen, Merck, Novartis, Pfizer Inc, Regeneron, Roche, Sanofi, Takeda, and UCB; and is the Director of Imaging Rheumatology BV.
DDG has received research grants and consultancy fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB; and has received consultancy fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc, and UCB. OF has received research grants and consultancy fees from AbbVie, Bristol- Myers Squibb, Novartis, and Pfizer Inc; and has received consultancy fees from Amgen, Celgene, Eli Lilly, and Janssen.
AK has received consultancy fees or other remuneration from Pfizer Inc. DG, CW, and LF are employees and shareholders of Pfizer Inc. Pfizer Inc were involved in the design of the study, collection, analysis, and interpretation of data, and review and approval of the manuscript.
Address correspondence to: Professor Désirée van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: mail@dvanderheijde.nl.